8-K: Patterson Companies Reports Mixed Q3 Results, Revises Fiscal 2024 Guidance

Patterson Companies' third quarter saw a slight increase in net sales, driven by dental consumables, but a decrease in net income, leading to a revised fiscal year earnings guidance.

Summary

• Patterson Companies reported a 1.0% year-over-year increase in net sales for the third quarter of fiscal year 2024, reaching $1.62 billion.
• Internal sales grew by 0.3%, with dental consumables showing strong growth of 6.3%, or 7.2% excluding certain infection control products.
• The company's GAAP earnings were $0.52 per diluted share, while adjusted earnings were $0.59 per diluted share.
• Net income attributable to Patterson Companies was $47.7 million, down from $53.9 million in the same quarter last year.
• The decrease in net income was primarily due to lower dental equipment sales and increased operating expenses.
• Patterson returned $148.8 million to shareholders through dividends and share repurchases in the third quarter.
• The company has revised its fiscal 2024 GAAP earnings guidance to $1.99 to $2.04 per diluted share and adjusted earnings guidance to $2.30 to $2.35 per diluted share.
• For the first nine months of fiscal 2024, consolidated net sales totaled $4.85 billion, a 2.0% year-over-year increase, with internal sales up 1.2%.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative due to mixed results, with strong performance in some areas offset by declines in others and a downward revision of earnings guidance. The company is facing headwinds and uncertainty.

Positives

• Dental consumables showed strong growth, with internal sales increasing by 6.3% year-over-year.
• The company returned a significant amount of capital to shareholders, totaling $148.8 million in the third quarter.
• Value-added services in the Animal Health segment saw a substantial increase of 44.2% in internal sales.
• Free cash flow improved by $11.9 million compared to the first nine months of fiscal 2023 due to a decreased level of working capital.

Negatives

• Net income attributable to Patterson Companies decreased to $47.7 million from $53.9 million in the same quarter last year.
• Dental equipment sales experienced a decline of 2.4% in internal sales.
• Animal Health segment internal sales decreased by 1.5% year-over-year.
• The company revised its fiscal 2024 earnings guidance downwards.

Risks

• The company faces headwinds in the dental equipment market.
• There are ongoing challenges from inflationary trends and higher interest rates.
• The broader economy is experiencing a slowdown.
• The company is exposed to macroeconomic and geopolitical uncertainty.
• There is a risk of material adverse developments associated with wide-spread public health concerns.
• The company is dependent on suppliers and faces risks of supply chain disruption.
• There are risks associated with the highly competitive dental and animal health supply markets.

Future Outlook

The company has revised its fiscal 2024 earnings guidance to reflect current expectations for the fourth quarter, including continued headwinds in the dental equipment market, and anticipates ongoing challenges from inflationary trends and higher interest rates.

Management Comments

• Patterson navigated a dynamic environment during our fiscal third quarter to deliver sales growth and gross margin expansion, said Don Zurbay, President and CEO of Patterson Companies.
• Our dental consumables and production animal businesses both continued to generate above-market sales growth, demonstrating the deep, differentiated value proposition we provide customers across the markets we serve.
• We have revised our guidance to reflect current expectations for the fourth quarter, including continued headwinds in the dental equipment market.
• During the fiscal third quarter, we remained focused on enhancing our long-term performance, including strategic investments in our capabilities and additional actions to enhance profitability.
• Our continued commitment to return capital to shareholders including nearly $150 million during the fiscal third quarter further underscores our confidence in the resilience of our end markets and Pattersons value creation potential.

Industry Context

The results reflect a mixed performance in the healthcare distribution sector, with strong growth in some areas like dental consumables offset by challenges in others, such as dental equipment. The company's focus on strategic investments and capital return aligns with industry trends of enhancing profitability and shareholder value.

Comparison to Industry Standards

• Patterson's dental consumables growth of 6.3% is a positive sign, indicating a strong position in that market segment, however, it is important to compare this to competitors such as Henry Schein and Benco Dental to see if this is above or below industry average.
• The decline in dental equipment sales of 2.4% suggests potential challenges in that area, which should be compared to the performance of competitors in the same market.
• The 44.2% increase in value-added services in the Animal Health segment is a significant positive, but it is important to compare this to other animal health distributors such as Covetrus and MWI Animal Health to see if this is an outlier or a trend.
• The revised earnings guidance indicates a cautious outlook, which is not uncommon in the current economic climate, but should be compared to the guidance of other companies in the same sector.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net income and the revised earnings guidance.
• Employees may be affected by the company's focus on enhancing profitability.
• Customers may benefit from the company's continued investment in its capabilities.
• Suppliers may be impacted by the company's focus on managing costs.

Next Steps

• The company will hold a conference call to discuss the results.
• The company will continue to focus on strategic investments and enhancing profitability.
• The company will continue to monitor the macroeconomic environment and its impact on the business.

Key Dates

Keywords

Patterson Companies, Dental Consumables, Animal Health, Financial Results, Earnings Guidance, Net Sales, Share Repurchase, Dividends, Healthcare Distribution, Medical Supplies